https://sputnikglobe.com/20230402/about-5000-dutch-women-file-case-against-abbvie-over-harmful-breast-implants-reports-say-1109051247.html
About 5,000 Dutch Women File Case Against AbbVie Over Harmful Breast Implants, Reports Say
About 5,000 Dutch Women File Case Against AbbVie Over Harmful Breast Implants, Reports Say
Sputnik International
About 5,000 women in the Netherlands filed a class action suit against biopharmaceutical company AbbVie over faulty breast implants that cause lymphoma,
2023-04-02T12:48+0000
2023-04-02T12:48+0000
2023-04-02T12:48+0000
world
netherlands
women
https://cdn1.img.sputnikglobe.com/img/106380/67/1063806796_0:68:2235:1325_1920x0_80_0_0_b470fe5ce69d4e5d051bf284ecad0130.jpg
Women's legal aid organization Bureau Clara Wichmann said that the case could be brought to court next week, with the total claim expected to amount to 900 million euros ($978 million) as further 55,000 women had AbbVie implants, according to the Dutch media.The case in particular focuses on implants named Biocell or Natrelle, produced by Irish-based pharmaceutical company Allergan, AbbVie’s subsidiary, the report said. Allergan's implants are suspected of increasing the risk of developing a rare form of lymphoma, according to the broadcaster. Bureau Clara Wichmann is seeking damages from AbbVie for the removal of breast implants and breast reconstruction. In addition, the organization intends to claim compensation for the women's pain and suffering that the operations will cause them, the report said. Allergan's implants have not been used in the Netherlands since 2018, later followed by a full withdrawal from the market in 2019. AbbVie is an American research and development pharmaceutical company founded in 2013 after separation from Abbott Laboratories. The company employs about 30,000 people. In 2019, AbbVie acquired Botox manufacturer Allergan for $63 billion.
netherlands
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
case against abbvie, harmful breast implants
case against abbvie, harmful breast implants
About 5,000 Dutch Women File Case Against AbbVie Over Harmful Breast Implants, Reports Say
MOSCOW (Sputnik) - About 5,000 women in the Netherlands filed a class action suit against biopharmaceutical company AbbVie over faulty breast implants that cause lymphoma, Dutch media reported on Sunday.
Women's legal aid organization Bureau Clara Wichmann said that the case could be brought to court next week, with the total claim expected to amount to 900 million euros ($978 million) as further 55,000 women had AbbVie implants, according to the Dutch media.
The case in particular focuses on implants named Biocell or Natrelle, produced by Irish-based pharmaceutical company Allergan, AbbVie’s subsidiary, the report said. Allergan's implants are suspected of increasing the risk of developing a rare form of lymphoma, according to the broadcaster.
Bureau Clara Wichmann is seeking damages from AbbVie for the removal of breast implants and breast reconstruction. In addition, the organization intends to claim compensation for the women's pain and suffering that the operations will cause them, the report said.
Allergan's
implants have not been used in the Netherlands since 2018, later followed by a full withdrawal from the market in 2019.
AbbVie is an American research and development pharmaceutical company founded in 2013 after separation from Abbott Laboratories. The company employs about 30,000 people. In 2019, AbbVie acquired Botox manufacturer Allergan for $63 billion.
